Wenn Krebszellen gären wird’s gefährlich

Zusammenfassung

Glukose kann zum Aggressivwerden einer Krebszelle beitragen, wenn die Energiegewinnung in der Zelle durch Gärung und nicht durch Verbrennung stattfindet. Das Gen Transketolase-like-1 (TKTL1) ist dabei von entscheidender Bedeutung: Sind Krebszellen TKTL1-positiv, findet die Energiegewinnung durch Vergärung statt, mit dem Endprodukt Milchsäure, die u. a. Wachstum und Metastasenbildung des Krebsgeschwürs begünstigt. Mit einer Umstellung der Ernährungs- und Lebensgewohnheiten kann diesem Prozess entgegengewirkt werden.

Der Beitrag informiert über die biochemischen Hintergründe, neue diagnostische Möglichkeiten sowie das Ernährungsprinzip nach Coy, mit dem Krebs aktiv begegnet werden kann.

Abstract

Glucose can contribute to the fact, that a cancer cell becomes aggressive, when the energy in the cell is produced by fermentation and not by oxidation. In this process, the gene Transketolase-like-1 (TKTL1) is of vital importance: if cancer cells are TKTL1 positive, the energy is produced by fermentation, and the end product is lactic acid, which encourages among other things the growth of the cancerous ulcer and the formation of metastases. A change of diet and of lifestyle can counteract this process.

The article informs about the biochemical background, new diagnostic opportunities, as well as the nutrition principle according to Coy, which can help to actively respond to cancer.

Schlüsselwörter

Coy-Prinzip - EDIM - Ernährung - Gärung - Krebs - TKTL1 - Warburg-Effekt

Keywords

Coy principle - EDIM - nutrition - fermentation - cancer - TKTL1 - Warburg effect

Literatur

• 01 Béliveau R, Gingras D. Krebszellen mögen keine Himbeeren. München; Kösel 2007
• 02 BIONITY .http://www.bionity.com/news/d/965005/
• 03 Coy F J, Dübel S, Kioschis P. et al . Molecular Cloning of Tissue-Specific Transcripts of a Transketolase-Related Gene: Implications for the Evolution of New Vertebrate Genes.  Genomics. 1996;  32 309-316
• 04 Coy F J, Dressler D, Wilde J, Schubert P. Mutations in the Transketolase-like Gene TKTL1: Clinical Implications for Neurodegenerative Diseases, Diabetes and Cancer.  Clin Lab. 2005;  51 257-273
• 05 Fischer K. et al . Inhibitory effect of tumor cell derived lactic acid on human T cells.  Blood. 2007;  109 (9) 3812-3819
• 06 FOCUS.  2009;  7 58
• 07 Friedrichsen H P. Mitochondriale Dysfunktion – Ursache chronischer Erkrankungen.  OM. 2008;  2 6-11
• 08 Gillies R J, Gatenby R A. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?.  J Bioenerg Biomembr. 2007;  39 (3) 251-257
• 09 Kohrenhagen N. et al . Expression of transketolase-like 1 (TKTL1) and p-Akt correlates with the progression of cervical neoplasia.  J Obstet Gynaecol Res. 2008;  34 (3) 293-300
• 10 Krockenberger M. et al . Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases.  Int J Gynecol Cancer. 2007;  17 (1) 101-106
• 11 Langbein S. et al . Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.  Br J Cancer. 2006;  94 (4) 578-585
• 12 Langbein S. et al . Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer.  Int J Cancer. 2008;  122 (11) 2422-2428
• 13 Leers M P G. et al . Circulating PSA-containing macrophages as possible target for the detection of prostate cancer.  AJCP. 2008;  129 649-656
• 14 Lu H, Forbes R A, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis.  J Biol Chem. 2002;  277 23111-23115
• 15 Otto C, Kaemmerer U, Illert B. et al . Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides.  BMC Cancer. 2008;  8 122
• 16 Pachmann K. et al . Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.  J Clin Oncol. 2008;  26 (8) 1208-1215
• 17 Richter H J, Heilmeyer P. Gesund durch Stress. Lünen; Systemed 2008
• 18 Santel T. et al . Curcumin inhibits glyoxalase 1 – a possible link to its anti-inflammatory and anti-tumor activity.  PLoS ONE. 2008;  3 (10) e3508
• 19 Sattler U G A, Walenta S, Mueller-Klieser W. Laktat und Redoxstatus in malignen Tumoren.  Anaesthesist. 2007;  5 38-41
• 20 Servan-Schreiber D. Das Antikrebs-Buch. München; Kunstmann 2008
• 21 Spitz J. Vitamin D – Das Sonnenhormon für unsere Gesundheit und der Schlüssel zur Prävention. mip-spitz-gbr 2008
• 22 Staiger W, Coy J F, Grobholz R. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer.  Oncol Rep. 2006;  16 (4) 657-661
• 23 Stern R. et al . Lactate stimulates fibroblast expression of hyaluronan and CD44: The Warburg effect reviced.  Exp Cell Res. 2002;  276 24-31
• 24 Vaughn A E, Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c.  Nature Cell Biology. 2008;  10 1477-1483
• 25 Völker H U. et al . Overexpression of transketolase TKTL1 is associated with shorter survival in laryngeal squamous cell carcinomas.  Eur Arch Otorhinolaryngol. 2007;  264 (12) 1431-1436
• 26 Völker H U. et al . Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas.  Am J Clin Pathol. 2008;  130 (1) 50-57
• 27 Walenta S. et al . High Lactate Levels Predict Likelihood of Metastases, Tumor Recurrence, and Restricted Patient Survival in Human Cervical Cancers.  Cancer Res. 2000;  60 916-921
• 28 Walenta S, Mueller-Klieser W F. Lactate: Mirror and motor of tumor malignancy.  Seminars in Radiation Oncology. 2004;  14 (3) 267-274
• 29 Warburg O, Posener K, Negelein E. Biochem Z. 1924;  152 309-344
• 30 Wegener B, Pfisterer M. TKTL1-Ernährung nach Dr. Coy: Therapieerfolge beim Glioblastom und metastasierten Kolonkarzinom.  Deutsche Zeitschrift für Onkologie. 2007;  4 170-174
• 31 Wittig R, Coy J F. The Role of Glucose Metabolism and Glucose-Associated Signalling in Cancer.  Perspectives in Medicinal Chemistry. 2007;  1 64-82
• 32 Wu H T. et al . Anaplastic nephroblastomas express transketolase-like enzyme 1.  J Clin Patholv. 2009;  DOI: 10.1136/jcp.2008.063966
• 33 Xu R. et al . Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance accociated with mitochondrial respiratory defect and hypoxia.  Cancer Res. 2005;  65 613-621
• 34 Xu X. Characterization of the functional role of the transketolase-like 1 (TKTL1) gene for glucose metabolism, cellular growth, and malignant transformation in vitro and in vivo. [Dissertation] Universität Heidelberg; 2008 http://archiv.ub.uni-heidelberg.de/volltextserver/volltexte/2008/8584/
• 35 Xu X, Hausen A zur, Coy J F. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells.  Int J Cancer. 2009;  124 1330-1337
• 36 Zerilli M. et al . Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases.  Cancer. 2008;  113 (5) 936-944
• 37 Zhang S. Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: A potential therapeutic target in nasopharyngeal carcinoma.  Cancer Biol Ther. 2008;  7 (4) 517-522

Korrespondenzadresse